Advanced Imaging


Industry News

Updated: July 8th, 2008 05:26 PM CDT

Abbott Announces FDA Clearance of Cell-Dyn Ruby(TM) Hematology Instrument

via PRNewswire


Abbott's CELL-DYN family of hematology instruments is well known for their efficiency and ability to provide fast access to patient results. Instruments range from larger analyzers that process a high number of patient samples tosmaller instruments designed for medium and small-volume facilities. Besides supplying standard CBC results, some instruments have additional features toaid in the evaluation of more complex disease states or infections including cancer, HIV and a variety of anemias.

About Abbott Diagnostics

Abbott Diagnostics is a global leader in in vitro diagnostics and offers abroad range of innovative instrument systems and tests for hospitals,reference labs, blood banks, physician offices and clinics. With more than6 5,000 institutional customers in more than 100 countries, Abbott's diagnostic products offer customers automation, convenience, cost effectiveness andflexibility. Abbott has helped transform the practice of medical diagnosisfrom an art to a science through the company's commitment to improving patient care and lowering costs. The history of Abbott Diagnostics is filled with examples of first-of-a-kind products and significant technological advancements.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on thecompany's Web site at


News stories provided by third parties are not edited by "Site Publication" staff. For suggestions and comments, please click the Contact link at the bottom of this page.

Subscribe to our RSS Feeds